2 in 2016 CloseUp concert drug deaths get life term | Inquirer News

2 in 2016 CloseUp concert drug deaths get life term

3 other suspects sentenced to 20 years in jail, fined P500,000 each
/ 06:25 AM April 07, 2018

The five suspects accused of selling illegal drugs during the CloseUp Forever Summer concert where five persons died due to drug overdose were arrested following a buy bust operation in Parañaque City.—INQUIRER FILE PHOTO

The Parañaque City Regional Trial Court (RTC) has sentenced to life imprisonment two of the five suspects accused of selling party drugs to five people who died of drug overdose during the CloseUp Forever Summer concert in a mall in Pasay City two years ago.

In a 37-page decision dated March 9 but announced on Friday, Judge Danilo Suarez of Parañaque RTC Branch 259 found accused Marc David Deen and Seergeoh Villanueva “guilty beyond reasonable doubt” for violating Section 5 of Republic Act No. 9165 or the trade, administration, delivery and transportation of illegal drugs after they sold 10 capsules with at least five grams of ketamine and methamphetamine hydrochloride to a National Bureau of Investigation  agent in a condominium in Parañaque on May 31, 2016.

Article continues after this advertisement

Deen and Villanueva were also ordered by the court to pay P5 million each.

FEATURED STORIES

5 fatalities

The two suspects were believed to be the source of the party drugs which killed five people during the CloseUp Forever Summer concert held on May 21, 2016.

Article continues after this advertisement

The fatalities were identified by police as Ariel Leal, 22; Lance Garcia, 36; Bianca Fontejon, 18; Ken Miyagawa, 18; and American national Eric Miller, 33.

Article continues after this advertisement

In an earlier report, the NBI officials said one of the victims tested positive for  MDMA (methylene homolog and methylenedioxy cathinone), a type of ecstasy combined with other chemicals unfit for human consumption.

Article continues after this advertisement

The NBI arrested Deen and Villanueva, and the three other accused—Erika  Dianne Valbuena, Thomas Lee Martin Halili and Martin Angelo Dimacali—in a buy-bust operation 10 days later.

Valbuena, Halili and Dimacali were sentenced to at least 20 years imprisonment and ordered to pay a fine of P500,000 each as a “single penalty” for multiple counts of violations of Section 11 of RA 9165 or possession of illegal drugs.

Article continues after this advertisement

Illegal possession of drugs

These include illegal possession of 72.9562 grams of cannabinol and ketamine; illegal possession of 67 grams of marijuana; 6.91 grams of MDMA-ecstasy;  3.67 grams of  Clonazepam, a sedative-hypnotic party drug; 1.79 grams of cocaine; 0.8 grams of ketamine and “shabu” or crystal meth; and eight grams more of meth and amphetamine.

The court also found the five accused guilty of violation of Section 12 or illegal possession of drug paraphernalia, sentencing them to at least six months imprisonment and a fine of P20,000.

The court, however, dismissed the accused for violation of Section 8 or manufacture of dangerous drugs and/or controlled precursors and essential chemicals for “insufficiency of evidence.”

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

The four male accused were committed to the New Bilibid Prison in Muntinlupa City while Valbuena was ordered transferred to the women’s correctional facility in Mandaluyong City.—WITH A REPORT FROM JHOANNA BALLARAN

TAGS: concert, convicted, Parañaque, RTC

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.